Oppenheimer & Co’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-29,600
| Closed | -$11K | – | 1393 |
|
|
2016
Q3 | $11K | Sell |
29,600
-48,000
| -62% | -$17.8K | ﹤0.01% | 1263 |
|
|
2016
Q2 | $36K | Buy |
77,600
+3,300
| +4% | +$1.53K | ﹤0.01% | 1197 |
|
|
2016
Q1 | $101K | Sell |
74,300
-20,000
| -21% | -$27.2K | ﹤0.01% | 1182 |
|
|
2015
Q4 | $138K | Buy |
94,300
+2,400
| +3% | +$3.51K | ﹤0.01% | 1181 |
|
|
2015
Q3 | $145K | Sell |
91,900
-45,000
| -33% | -$71K | ﹤0.01% | 1223 |
|
|
2015
Q2 | $233K | Buy |
136,900
+8,800
| +7% | +$15K | 0.01% | 1212 |
|
|
2015
Q1 | $178K | Sell |
128,100
-33,700
| -21% | -$46.8K | ﹤0.01% | 1338 |
|
|
2014
Q4 | $244K | Sell |
161,800
-44,500
| -22% | -$67.1K | 0.01% | 1118 |
|
|
2014
Q3 | $425K | Buy |
206,300
+26,601
| +15% | +$54.8K | 0.01% | 918 |
|
|
2014
Q2 | $549K | Buy |
179,699
+103,000
| +134% | +$315K | 0.02% | 824 |
|
|
2014
Q1 | $192K | Sell |
76,699
-8,101
| -10% | -$20.3K | 0.01% | 1255 |
|
|
2013
Q4 | $421K | Buy |
84,800
+55,800
| +192% | +$277K | 0.01% | 881 |
|
|
2013
Q3 | $66K | Buy |
+29,000
| New | +$66K | ﹤0.01% | 1270 |
|